Milestone Pharmaceuticals Inc. (MIST) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Milestone Pharmaceuticals...

    NASDAQ: MIST · Real-Time Price · USD
    1.71
    -0.01 (-0.58%)
    At close: Sep 10, 2025, 3:59 PM
    1.76
    2.92%
    Pre-market: Sep 11, 2025, 07:18 AM EDT

    Milestone Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 1M 5M 15M
    Cost of Revenue
    		 646K n/a 480K n/a
    Gross Profit
    		 -646K 1M 4.52M 15M
    Operating Income
    		 -42.1M -61.1M -59.64M -43.07M
    Interest Income
    		 4.16M 3.97M 1.25M 220K
    Pretax Income
    		 -41.78M -59.69M -58.39M -42.85M
    Net Income
    		 -41.52M -59.69M -57.13M -42.63M
    Selling & General & Admin
    		 27.1M 31.05M 24.81M 19.4M
    Research & Development
    		 14.62M 31.05M 39.83M 38.67M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 41.72M 62.1M 64.64M 58.07M
    Interest Expense
    		 -3.58M 2.55M n/a n/a
    Selling & Marketing Expenses
    		 10.36M 15.11M 9.1M 7M
    Cost & Expenses
    		 42.36M 62.1M 64.64M 58.07M
    Income Tax Expense
    		 -259K n/a -1.25M -220K
    Shares Outstanding (Basic)
    		 62.21M 42.96M 42.45M 41.83M
    Shares Outstanding (Diluted)
    		 62.21M 42.96M 42.45M 41.83M
    EPS (Basic)
    		 -0.67 -1.39 -1.35 -1.02
    EPS (Diluted)
    		 -0.67 -1.39 -1.35 -1.02
    EBITDA
    		 -42.1M -56.84M -58.36M -42.98M
    EBIT
    		 -38.2M -57.13M -58.84M -43.07M
    Depreciation & Amortization
    		 -3.9M 92K 480K 362K

    Add to Watchlist